S. Yoshioka

Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles, CYP2C19m1 in exon 5 and CYP2C19m2 in exon 4, in Japanese subjects

S. Higuchi, I. Ieiri, A. Urae, 1996 .

Enhancement of Fibrinolysis by EF6265 [(S)-7-Amino-2-[[[(R)-2-methyl-1-(3-phenylpropanoylamino)propyl]hydroxyphosphinoyl] methyl]heptanoic Acid], a Specific Inhibitor of Plasma Carboxypeptidase B

M. Nomoto, C. Kikuchi, H. Ishii, 2004, Journal of Pharmacology and Experimental Therapeutics.

Stereoselective 4'-hydroxylation of phenytoin: relationship to (S)-mephenytoin polymorphism in Japanese.

S. Higuchi, N. Tashiro, I. Ieiri, 1997, British journal of clinical pharmacology.

Predicting Interactions between Medicinal Drugs and New Supplements

N. Suzuki, T. Kubota, Norihito Ishibashi, 2010 .

Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles, C gamma P2C19m1 in exon 5 and C gamma P2C19m2 in exon 4, in Japanese subjects.

S. Higuchi, I. Ieiri, A. Urae, 1996, Clinical pharmacology and therapeutics.